Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 51, 2022 - Issue 2
109
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Association of TNFSF4 Gene Polymorphisms and Plasma TNFSF4 Level with Risk of Systemic Lupus Erythematosus in a Chinese Population

, , &

References

  • An J, Ding S, Li S, Sun L, Chang X, Huang Z, Zhou B, Fang C, Liu C, Zhang X. 2019. Enhancement of the soluble form of OX40 and OX40L costimulatory molecules but reduction of the membrane form in type 1 diabetes (T1D). J Immunol Res. 2019:1780567.
  • Barrios CS, Johnson BD, Henderson DJ Jr, Fink JN, Kelly KJ, Kurup VP. 2005. The costimulatory molecules CD80, CD86 and OX40L are up-regulated in Aspergillus fumigatus sensitized mice. Clin Exp Immunol. 142:242–50.
  • Chua KH, Ooh YY, Chai HC. 2016. TNFSF4 polymorphisms are associated with systemic lupus erythematosus in the Malaysian population. Int J Immunogenet. 43(5):303–09.
  • Cortini A, Ellinghaus U, Malik TH, Cunninghame Graham DS, Botto M, Vyse TJ. 2017. B cell OX40L supports T follicular helper cell development and contributes to SLE pathogenesis. Ann Rheum Dis. 76(12):2095–103.
  • Gourh P, Arnett FC, Tan FK, Assassi S, Divecha D, Paz G, McNearney T, Draeger H, Reveille JD, Mayes MD, et al. 2010. Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis. Ann Rheum Dis. 69(3):550–55.
  • Gupta V, Kumar S, Pratap A, Singh R, Kumari R, Kumar S, Aggarwal A, Misra R. 2018. Association of ITGAM, TNFSF4, TNFAIP3 and STAT4 gene polymorphisms with risk of systemic lupus erythematosus in a North Indian population. Lupus. 27(12):1973–79.
  • Huang Q, Yang QD, Tan XL, Feng J, Tang T, Xia J, Zhang L, Huang L, Bai YP, Liu YH. 2014. Absence of association between atherosclerotic cerebral infarction and TNFSF4/TNFRSF4 single nucleotide polymorphisms rs1234313, rs1234314 and rs17568 in a Chinese population. J Int Med Res. 42(2):436–43.
  • Kailashiya V, Singh U, Rana R, Singh NK, Dash D, Kailashiya J. 2019. Regulatory T cells and their association with serum markers and symptoms in systemic lupus erythematosus and rheumatoid arthritis. Immunol Invest. 48(1):64–78.
  • Kumar P, Lele SS, Ragothaman VK, Raghunathan D, Epstein AL, Chiba S, Prabhakar BS. 2019. OX40L-JAG1-induced expansion of lineage-stable regulatory T cells involves noncanonical NF-κB signaling. J Immunol. 203(12):3225–36.
  • Laustsen JK, Rasmussen TK, Stengaard-Pedersen K, Hørslev-Petersen K, Hetland ML, Østergaard M, Junker P, Hvid M, Deleuran B. 2014. Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis. Arthritis Res Ther. 16(5):474.
  • Li L, Chen S, Wen X, Wang Q, Lv G, Li J, Yang F, Zhang F, Li Y. 2017. Positive association between ANKRD55 polymorphism 7731626 and dermatomyositis/polymyositis with interstitial lung disease in Chinese han population. Biomed Res Int. 2017:2905987.
  • Lian Z, Liu J, Shi Z, Chen H, Zhang Q, Feng H, Du Q, Miao X, Zhou H. 2017. Association of TNFSF4 polymorphisms with neuromyelitis optica spectrum disorders in a Chinese population. J Mol Neurosci. 63(3–4):396–402.
  • Linton PJ, Bautista B, Bierderman E, Bradley ES, Harbertson J, Kondrack RM, Padrick RC, Bradley L. 2003. Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J Exp Med. 197(7):875–83.
  • Lu C, Jia H, Xu A. 2018. The rs3850641 polymorphism of the TNFSF4 gene increases the risk of myocardial infarction in a Chinese Han population. Biosci Rep. 38(4):BSR20180526.
  • Lu S, Song S, Hou S, Li H, Yang P. 2016. Association of TNFSF4 polymorphisms with Vogt-Koyanagi-Harada and Behcet’s Disease in Han Chinese. Sci Rep. 6:37257.
  • Maalhagh M, Shojaei M, Erfanian S, Sotoodeh Jahromi A, Sanie MS, Yusefi A, Zabetian H, Hakimelahi H, Madani A, Hojjat-Farsangi M. 2015. Lack of association between rs17568 polymorphism in OX40 gene and myocardial infarction, Southern of Iran. Glob J Health Sci. 8(6):41–46.
  • Rajabi P, Alaee M, Mousavizadeh K, Samadikuchaksaraei A. 2012. Altered expression of TNFSF4 and TRAF2 mRNAs in peripheral blood mononuclear cells in patients with systemic lupus erythematosus: association with atherosclerotic symptoms and lupus nephritis. Inflamm Res. 61(12):1347–54.
  • Sitrin J, Suto E, Wuster A, Eastham-Anderson J, Kim JM, Austin CD, Lee WP, Behrens TW. 2017. The Ox40/Ox40 ligand pathway promotes pathogenic Th cell responses, plasmablast accumulation, and lupus nephritis in NZB/W F1 mice. J Immunol. 199(4):1238–49.
  • Song RH, Wang Q, Yao QM, Shao XQ, Li L, Wang W, An XF, Li Q, Zhang JA. 2016. TNFSF4 gene variations are related to early-onset autoimmune thyroid diseases and hypothyroidism of Hashimoto’s thyroiditis. Int J Mol Sci. 17(8):1369.
  • Sun F, Li P, Chen H, Wu Z, Xu J, Shen M, Leng X, Shi Q, Zhang W, Tian X, et al. 2013. Association studies of TNFSF4, TNFAIP3 and FAM167A-BLK polymorphisms with primary Sjogren’s syndrome in Han Chinese. J Hum Genet. 58(7):475–79.
  • Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25(11):1271–77.
  • Weiguang Y, Dalin L, Lidan X, Yonggang C, Shuang C, Yanhong L, Fengyan X, Zhenkun F, Da P, Dianjun L. 2012. Association of OX40L polymorphisms with sporadic breast cancer in northeast Chinese Han population. PLoS One. 7(8):e41277.
  • Wu J, Cui Y, Zhu W, Bai S, Zhao N, Liu B. 2019. Citical role of OX40/OX40L in ILC2-mediated activation of CD4(+)T cells during respiratory syncytial virus infection in mice. Int Immunopharmacol. 76:105784.
  • Zhou XJ, Cheng FJ, Qi YY, Zhao MH, Zhang H. 2013. A replication study from Chinese supports association between lupus-risk allele in TNFSF4 and renal disorder. Biomed Res Int. 2013:597921.
  • Zhou Z, Tian Z, Zhang M, Zhang Y, Ni B, Hao F. 2018. Upregulated IL-1 receptor-associated kinase 1 (IRAK1) in systemic lupus erythematosus: IRAK1 inhibition represses Th17 differentiation with therapeutic potential. Immunol Invest. 47(5):468–83.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.